Key clinical point: CLL model and DLBCL model both have high sensitivity and specificity.
Major finding: Combination of 1445 cm-1 and 1655 cm-1 could discriminate DLBCL from CLL.
Study details: Analysis of blood plasma from 33 DLBCL patients, 39 CLL patients, and 30 healthy volunteers.
Disclosures: The study was supported by the National Natural Science Foundation of China. The authors reported that they had no competing interests.
Bai Y et al. Journal of Pharmaceutical and Biomedical Analysis. 2020; doi.org/10.1016/j.jpba.2020.113514.